Ginés Luengo-Gil

12PUBLICATIONS
54CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 11, 2026
Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies.

Daniel Ortega-Álvarez, David Tébar-García, Marta Casado-Peláez

|Dec 11, 2025
Safety and Effectiveness of Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Posterior Fossa Brain Metastases: A Single-Centre Experience.

José Manuel Sánchez-Villalobos, Alfredo Serna-Berna, Juan Salinas-Ramos

|Sep 27, 2025
Effectiveness and Safety of Sacituzumab Govitecan in Real-World Clinical Practice in Patients with Metastatic Triple-Negative and HR+/HER2-Negative Breast Cancer.

Fernando Lago-Ballester, Adrián Martínez-Orea, Ana Laorden-Carrasco

|Aug 14, 2025
Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions.

Fátima Postigo-Corrales, Asunción Beltrán-Videla, Antonio David Lázaro-Sánchez

|Apr 17, 2025
Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers.

Alberto Sánchez-Espinosa, José García-Rodríguez, Virginia Alonso-Aguirre

|Feb 26, 2025
Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report.

Antonio David Lazaro Sanchez, Javier David Benitez Fuentes, Ginés Luengo Gil

Pageof 2

Frequent Collaborators

4 joint publications

Irene Martínez-Martínez

4 joint publications

Vicente Vicente

3 joint publications

Pablo Conesa-Zamora

2 joint publications

Antonio David Lázaro-Sánchez